Clinical trial
New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis
NCT00001736 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00001736 |
|---|---|
| Title | New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis |
| Official title | Safety and Efficacy Trial of a Proposed NDA Formulation of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cystinosis |
| Intervention type | Drug |
| Interventions | Cysteamine |
| Enrollment | 51 |
| Start date | May 1, 1998 |
| Completion | Mar 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: